U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 04:39:03 GMT 2025
Edited
by admin
on Wed Apr 02 04:39:03 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1|LAMDA
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
2RIB5BB8CX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Indenebart
INN   USAN  
Official Name English
MEDI-1341
Preferred Name English
Immunoglobulin G1[239-phenyalanine,240-glutamic acid,336-serine], anti-(human ?-synuclein) (human monoclonal TAK-341 ?1-chain), disulfide with human monoclonal TAK-341 ?-chain, dimer
Common Name English
MEDI1341
Code English
indenebart [INN]
Common Name English
TAK-341
Code English
INDENEBART [USAN]
Common Name English
immunoglobulin G1-lambda2, anti-[Homo sapiens SNCA (synuclein alpha, PARK1, PARK4, Parkinson disease (autosomal dominant, Lewy body) 4, synuclein alpha (non A4 component of amyloid precursor))], Homo sapiens monoclonal antibody
Common Name English
H-gamma1 heavy chain Homo sapiens (1-452) [VH (Homo sapiens IGHV3-23*01 (96.9%) -(IGHD) -IGHJ6*01 (94.4%)) [8.8.15] (26-33.51-58.97-111) (1-122) -Homo sapiens IGHG1*03, G1m3, nG1m1 CH1 R120, CH3 E12, M14, G1v39 CH2 F1.3, E1.2, S116 (CH1 R120 (219) (123-2
Common Name English
Code System Code Type Description
SMS_ID
300000054615
Created by admin on Wed Apr 02 04:39:03 GMT 2025 , Edited by admin on Wed Apr 02 04:39:03 GMT 2025
PRIMARY
FDA UNII
2RIB5BB8CX
Created by admin on Wed Apr 02 04:39:03 GMT 2025 , Edited by admin on Wed Apr 02 04:39:03 GMT 2025
PRIMARY
INN
13006
Created by admin on Wed Apr 02 04:39:03 GMT 2025 , Edited by admin on Wed Apr 02 04:39:03 GMT 2025
PRIMARY
USAN
MN-52
Created by admin on Wed Apr 02 04:39:03 GMT 2025 , Edited by admin on Wed Apr 02 04:39:03 GMT 2025
PRIMARY
NCI_THESAURUS
C206924
Created by admin on Wed Apr 02 04:39:03 GMT 2025 , Edited by admin on Wed Apr 02 04:39:03 GMT 2025
PRIMARY
CAS
2864437-88-5
Created by admin on Wed Apr 02 04:39:03 GMT 2025 , Edited by admin on Wed Apr 02 04:39:03 GMT 2025
PRIMARY
From To
1_22 1_96
2_22 2_96
1_225 3_220
2_225 4_220
3_22 3_96
4_22 4_96
1_149 1_205
1_266 1_326
1_372 1_430
2_149 2_205
2_266 2_326
2_372 2_430
1_231 2_231
1_234 2_234
3_143 3_202
4_143 4_202
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_302
N 2_302
Related Record Type Details
TARGET -> INHIBITOR
IC50
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [3_1] [4_1] N-TERMINUS Q PIDOLIC ACID SZB83O1W42
AMINO ACID REMOVAL [1_452] [2_452] C-TERMINUS K LYSINE K3Z4F929H6
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL